EcoR1 Capital to Engage with Galapagos (GLPG) on Company Performance and Governance

Key Summary: On August 23, 2024, EcoR1 Capital (9.9%) announced plans to discuss company performance, operations, strategic opportunities, and governance, including Board composition, with management and the board.

Market Cap: $1.7 billion | GALAPAGOS NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the Uni…